Clinical Trial Update: CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer [Phase 2]

View source ↗

Summary

This report summarizes results from a Phase 2 trial evaluating two methods of combining cetuximab with gemcitabine in patients with advanced non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED